GOAMPA
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

GOAMPA Trademark

Serial Number: 50111335

GOAMPA is a trademark filed by Neurocrine Switzerland GmbH on September 16, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Neurocrine Switzerland GmbH (2 trademarks)

Hegenheimermattweg 167A
Allschwil 4123 , CH

Entity Type: 27

Trademark Details

Filing Date

September 16, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for human use; pharmaceutical preparations for the treatment of psychiatric disorders; pharmaceutical preparations for the treatment of mood disorders; pharmaceutical preparations for the treatment of depressive disorders; pharmaceutical preparations for the treatment of anhedonia; pharmaceutical preparations for the treatment of major depressive disorder (MDD); pharmaceutical preparations for the adjunctive treatment of major depressive disorder; pharmaceutical preparations for the treatment of bipolar disorder, post-traumatic stress disorder (PTSD), and attention-deficit / hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparations for the treatment of central nervous system disorders

Providing medical information; providing medical information relating to treatment of major depressive disorder; providing medical information relating to treatment of psychiatric, mood, neurological, and central nervous system disorders

Pharmaceutical research and development services; medical and scientific research in the field of major depressive disorder; medical and scientific research in the field of psychiatric, mood, neurological, and central nervous system disorders; providing medical and scientific information in the field of pharmaceutical research and development

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 16, 2026 MAFR
NEW APPLICATION ENTERED
Sep 16, 2026 NWAP